Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,178,425 | 11,659,040 | 11,368,100 | 10,157,940 | 9,758,392 |
| Marketable Securities | N/A | N/A | N/A | 123,254 | 289,787 |
| Receivables | 8,574,060 | 8,156,245 | 8,090,353 | 8,201,414 | 9,503,166 |
| Inventories | 8,830,337 | 7,704,125 | 7,626,687 | 7,235,366 | 8,722,866 |
| Other current assets | 3,444,978 | 2,266,260 | 2,446,690 | 1,962,076 | 2,867,299 |
| TOTAL | $29,027,800 | $29,785,670 | $29,531,830 | $27,680,050 | $31,141,510 |
| Non-Current Assets | |||||
| PPE Net | 11,397,830 | 10,827,140 | 11,087,030 | 11,040,710 | 13,819,400 |
| Investments And Advances | 4,017,762 | 3,236,049 | 3,198,074 | 2,971,430 | 6,591,999 |
| Intangibles | 78,092,450 | 60,294,720 | 56,620,290 | 57,277,760 | 71,436,580 |
| Other Non-Current Assets | 9,036,958 | 8,689,751 | 15,392,806 | 14,647,300 | 6,473,691 |
| TOTAL | $102,545,000 | $83,047,660 | $86,298,200 | $85,937,200 | $98,321,670 |
| Total Assets | $131,572,800 | $112,833,300 | $115,830,000 | $113,617,200 | $129,463,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,109,573 | 1,441,132 | 1,952,042 | 3,815,334 | 2,044,463 |
| Accounts payable and accrued liabilities | 5,953,421 | 5,236,680 | 4,755,060 | 4,238,397 | 4,853,274 |
| Other current liabilities | 11,458,060 | 10,793,240 | 11,478,760 | 10,628,750 | 10,425,700 |
| TOTAL | $20,521,060 | $17,471,050 | $18,185,870 | $18,682,480 | $17,323,440 |
| Non-Current Liabilities | |||||
| Long Term Debt | 25,990,270 | 16,192,680 | 18,607,480 | 14,566,230 | 17,647,790 |
| Other Non-Current Liabilities | 11,186,432 | 11,369,683 | 12,522,282 | 12,405,392 | 14,079,947 |
| TOTAL | $41,331,460 | $29,513,260 | $33,766,790 | $30,298,380 | $37,342,700 |
| Total Liabilities | $61,852,510 | $46,984,310 | $51,952,660 | $48,980,860 | $54,666,130 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,490,909 | N/A | N/A | 2,611,394 | 2,638,735 |
| Common Shares | 2,946,595 | 2,834,792 | 2,859,454 | 2,899,254 | 3,508,023 |
| Other shareholders' equity | 4,236,555 | 3,257,708 | 5,716,476 | 4,316,226 | 2,353,327 |
| TOTAL | $69,720,340 | $65,849,020 | $63,877,380 | $64,636,380 | $74,797,050 |
| Total Liabilities And Equity | $131,572,850 | $112,833,330 | $115,830,040 | $113,617,240 | $129,463,180 |